dermatoses research hub

AN OPEN-LABEL, RANDOMIZED, SINGLE DOSE, TWO-STAGE CROSSOVER ADAPTIVE BIOEQUIVALENCE STUDY OF TRIAMCINOLONE ACETONIDE 40 MG/ML STERILE INJECTABLE SUSPENSION (Test product–Lisapharma S.p.A) VERSUS KENACORT® 40 MG/ML SUSPENSION (Reference product – Bristol Myers Squibb) AFTER INTRAMUSCULAR ADMINISTRATION TO HEALTHY VOLUNTEERS

This study compares a new version of the steroid injection triamcinolone acetonide from Lisapharma with the existing Kenacort version. It's for healthy volunteers to see if the body handles both medicines in the same way. This is important to ensure the new version works just as well and is equally safe.